Literature DB >> 1204595

Diphenylhydantoin serum levels, toxicity, and neuropsychological performance in patients with epilepsy.

C B Dodrill.   

Abstract

The neuropsychological effects of diphenylhydantoin were assessed in 70 adults having primarily psychomotor and major motor seizures. All patients were stabilized on diphenylhydantoin alone, and assessment of this drug by gas-liquid chromatography provided a basis for dichotomizing the group into High and Low drug groups, both with and without toxic patients. In addition, patients showing signs of toxicity were contrasted with those not showing such signs. In each of these comparisons, control was maintained with respect to the variables of age, education, age at onset of disorder, and duration of disorder. Neuropsychological assessment was by means of the test battery originated by Halstead and developed by Reitan. Results showed that the High and Toxic Groups rather consistently did more poorly on all tasks than the Low and Nontoxic Groups. However, differences which were statistically significant appeared only in connection with tasks which had a heavy motor component. Possible reasons for the lack of statistically significant differences on the higher level mental tasks were presented.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1204595     DOI: 10.1111/j.1528-1157.1975.tb04741.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  6 in total

Review 1.  Dose-related adverse effects of anticonvulsants.

Authors:  A S Troupin
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

Review 2.  Adverse neuropsychiatric effects of anticonvulsant drugs.

Authors:  E H Reynolds; M R Trimble
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

3.  Cognitive Adverse Effects of Antiepileptic Drugs : Incidence, Mechanisms and Therapeutic Implications.

Authors:  R Kälviäinen; M Äikiä; P J Riekkinen
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

4.  Anticonvulsant serum levels: relationship to impairments of cognitive functioning.

Authors:  P J Thompson; M R Trimble
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-03       Impact factor: 10.154

5.  Cognitive development in epilepsy. The relative influence of epileptic activity and of brain damage.

Authors:  H Niemann; H E Boenick; R C Schmidt; G Ettlinger
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

6.  Sodium valproate and cognitive functioning in normal volunteers.

Authors:  P J Thompson; M R Trimble
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.